Sign in

CIK 0001787400

  • Non-accelerated filer
  • Smaller reporting company

Nkarta, Inc.

Sign in to watch
Ticker
NKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474515206
Phone
+1 925-407-1049
Business address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale Chief Technical Officer sold 8,367 shares at $12.51 ($104,671)
  2. 4 Open-market sale Chief Scientific Officer sold 4,143 shares at $12.00 ($49,716)
  3. 4 Open-market sale Chief Medical Officer sold 3,552 shares at $8.74 ($31,044)
  4. 4 Open-market sale Chief Scientific Officer sold 4,560 shares at $8.74 ($39,854)
  5. 4 Open-market sale Chief Technical Officer sold 2,512 shares at $8.74 ($21,955)
  6. 4 Open-market sale Chief Executive Officer sold 9,697 shares at $8.74 ($84,752)
  7. 4 Open-market sale Chief Legal Officer sold 4,554 shares at $8.74 ($39,802)
  8. 4 Grant or award Chief Medical Officer acquired 56,000 shares (grant or award)
  9. 4 Grant or award Chief Technical Officer acquired 56,000 shares (grant or award)
  10. 4 Grant or award Chief Scientific Officer acquired 56,000 shares (grant or award)
  11. 4 Grant or award Chief Executive Officer acquired 85,000 shares (grant or award)
  12. 4 Grant or award Levin Alyssa acquired 56,000 shares (grant or award)
  13. 4 Grant or award Chief Legal Officer acquired 56,000 shares (grant or award)
  14. 4 Open-market sale Chief Medical Officer sold 1,331 shares at $1.83 ($2,436)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale Chief Scientific Officer sold 439 shares at $4.85 ($2,129)
  19. 4 Open-market sale Chief Technical Officer sold 221 shares at $4.85 ($1,072)
  20. 4 Open-market sale Chief Legal Officer sold 701 shares at $4.85 ($3,400)

Page 4 of 11 · 218 filings